vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and e.l.f. Beauty, Inc. (ELF). Click either name above to swap in a different company.

e.l.f. Beauty, Inc. is the larger business by last-quarter revenue ($489.5M vs $487.7M, roughly 1.0× CLOVER HEALTH INVESTMENTS, CORP.). e.l.f. Beauty, Inc. runs the higher net margin — 8.0% vs -10.1%, a 18.2% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 37.8%). e.l.f. Beauty, Inc. produced more free cash flow last quarter ($52.8M vs $-69.0M).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

e.l.f. Beauty, Inc. is an American cosmetics brand based in Oakland, California. It was founded by Joseph Shamah and Scott Vincent Borba in 2004. The company sells items include bath and skin-care products, mineral-based makeup, professional tools, eyeliners, lipstick, glosses, blushes, bronzers, brushes and mascara. Its products are sold in 18 countries and in several stores including Target, Kmart, Dollar General and Walmart. Over half the company's sales come from its website, which is als...

CLOV vs ELF — Head-to-Head

Bigger by revenue
ELF
ELF
1.0× larger
ELF
$489.5M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+7.0% gap
CLOV
44.7%
37.8%
ELF
Higher net margin
ELF
ELF
18.2% more per $
ELF
8.0%
-10.1%
CLOV
More free cash flow
ELF
ELF
$121.8M more FCF
ELF
$52.8M
$-69.0M
CLOV

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CLOV
CLOV
ELF
ELF
Revenue
$487.7M
$489.5M
Net Profit
$-49.3M
$39.4M
Gross Margin
71.0%
Operating Margin
-10.1%
13.8%
Net Margin
-10.1%
8.0%
Revenue YoY
44.7%
37.8%
Net Profit YoY
-123.2%
128.1%
EPS (diluted)
$0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
ELF
ELF
Q4 25
$487.7M
$489.5M
Q3 25
$496.6M
$343.9M
Q2 25
$477.6M
$353.7M
Q1 25
$462.3M
Q4 24
$337.0M
Q3 24
$331.0M
Q2 24
$356.3M
Q1 24
$346.9M
Net Profit
CLOV
CLOV
ELF
ELF
Q4 25
$-49.3M
$39.4M
Q3 25
$-24.4M
$3.0M
Q2 25
$-10.6M
$33.3M
Q1 25
$-1.3M
Q4 24
$-22.1M
Q3 24
$-9.2M
Q2 24
$7.4M
Q1 24
$-19.2M
Gross Margin
CLOV
CLOV
ELF
ELF
Q4 25
71.0%
Q3 25
69.4%
Q2 25
69.1%
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
ELF
ELF
Q4 25
-10.1%
13.8%
Q3 25
-4.9%
2.2%
Q2 25
-2.2%
13.8%
Q1 25
-0.3%
Q4 24
-6.4%
Q3 24
-2.7%
Q2 24
2.0%
Q1 24
-6.5%
Net Margin
CLOV
CLOV
ELF
ELF
Q4 25
-10.1%
8.0%
Q3 25
-4.9%
0.9%
Q2 25
-2.2%
9.4%
Q1 25
-0.3%
Q4 24
-6.6%
Q3 24
-2.8%
Q2 24
2.1%
Q1 24
-5.5%
EPS (diluted)
CLOV
CLOV
ELF
ELF
Q4 25
$0.65
Q3 25
$0.05
Q2 25
$0.58
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
ELF
ELF
Cash + ST InvestmentsLiquidity on hand
$78.3M
$196.8M
Total DebtLower is stronger
$816.7M
Stockholders' EquityBook value
$308.7M
$1.2B
Total Assets
$541.0M
$2.3B
Debt / EquityLower = less leverage
0.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
ELF
ELF
Q4 25
$78.3M
$196.8M
Q3 25
$194.4M
Q2 25
$170.0M
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Q1 24
$208.3M
Total Debt
CLOV
CLOV
ELF
ELF
Q4 25
$816.7M
Q3 25
$831.6M
Q2 25
$256.7M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
ELF
ELF
Q4 25
$308.7M
$1.2B
Q3 25
$340.9M
$1.1B
Q2 25
$344.2M
$804.9M
Q1 25
$336.1M
Q4 24
$341.1M
Q3 24
$342.2M
Q2 24
$324.9M
Q1 24
$292.5M
Total Assets
CLOV
CLOV
ELF
ELF
Q4 25
$541.0M
$2.3B
Q3 25
$559.7M
$2.3B
Q2 25
$575.0M
$1.3B
Q1 25
$583.7M
Q4 24
$580.7M
Q3 24
$653.0M
Q2 24
$674.2M
Q1 24
$671.8M
Debt / Equity
CLOV
CLOV
ELF
ELF
Q4 25
0.70×
Q3 25
0.73×
Q2 25
0.32×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
ELF
ELF
Operating Cash FlowLast quarter
$-66.9M
$59.4M
Free Cash FlowOCF − Capex
$-69.0M
$52.8M
FCF MarginFCF / Revenue
-14.1%
10.8%
Capex IntensityCapex / Revenue
0.4%
1.4%
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
ELF
ELF
Q4 25
$-66.9M
$59.4M
Q3 25
$12.1M
$23.4M
Q2 25
$5.4M
$27.2M
Q1 25
$-16.3M
Q4 24
$34.8M
Q3 24
$50.0M
Q2 24
$44.8M
Q1 24
$25.9M
Free Cash Flow
CLOV
CLOV
ELF
ELF
Q4 25
$-69.0M
$52.8M
Q3 25
$11.4M
$16.6M
Q2 25
$4.8M
$20.1M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
ELF
ELF
Q4 25
-14.1%
10.8%
Q3 25
2.3%
4.8%
Q2 25
1.0%
5.7%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
ELF
ELF
Q4 25
0.4%
1.4%
Q3 25
0.1%
2.0%
Q2 25
0.1%
2.0%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
ELF
ELF
Q4 25
1.51×
Q3 25
7.82×
Q2 25
0.82×
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons